DBVT
Price
$9.00
Change
+$0.49 (+5.76%)
Updated
Aug 1 closing price
Capitalization
259.34M
GLSI
Price
$11.09
Change
+$0.15 (+1.37%)
Updated
Aug 1 closing price
Capitalization
149.19M
7 days until earnings call
Interact to see
Advertisement

DBVT vs GLSI

Header iconDBVT vs GLSI Comparison
Open Charts DBVT vs GLSIBanner chart's image
DBV Technologies S.A
Price$9.00
Change+$0.49 (+5.76%)
Volume$24.53K
Capitalization259.34M
Greenwich LifeSciences
Price$11.09
Change+$0.15 (+1.37%)
Volume$45.64K
Capitalization149.19M
DBVT vs GLSI Comparison Chart in %
Loading...
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DBVT vs. GLSI commentary
Aug 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBVT is a Hold and GLSI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 04, 2025
Stock price -- (DBVT: $9.00 vs. GLSI: $11.09)
Brand notoriety: DBVT and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DBVT: 79% vs. GLSI: 81%
Market capitalization -- DBVT: $259.34M vs. GLSI: $149.19M
DBVT [@Biotechnology] is valued at $259.34M. GLSI’s [@Biotechnology] market capitalization is $149.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBVT’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • DBVT’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, DBVT is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBVT’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 5 bullish TA indicator(s).

  • DBVT’s TA Score: 4 bullish, 6 bearish.
  • GLSI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GLSI is a better buy in the short-term than DBVT.

Price Growth

DBVT (@Biotechnology) experienced а -4.81% price change this week, while GLSI (@Biotechnology) price change was -4.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

DBVT is expected to report earnings on Jul 29, 2025.

GLSI is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DBVT($259M) has a higher market cap than GLSI($149M). DBVT YTD gains are higher at: 191.262 vs. GLSI (-1.247). GLSI has higher annual earnings (EBITDA): -16.75M vs. DBVT (-115.51M). DBVT has more cash in the bank: 103M vs. GLSI (2.75M). DBVT (0) and GLSI (0) have equivalent revenues.
DBVTGLSIDBVT / GLSI
Capitalization259M149M174%
EBITDA-115.51M-16.75M689%
Gain YTD191.262-1.247-15,342%
P/E RatioN/AN/A-
Revenue00-
Total Cash103M2.75M3,745%
Total Debt8.29MN/A-
FUNDAMENTALS RATINGS
DBVT: Fundamental Ratings
DBVT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DBVTGLSI
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 19 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLTTF5.38N/A
N/A
Dalata Hotel Group PLC
CTPCY6.54N/A
N/A
Citic Ltd
HUSQF5.56N/A
N/A
Husqvarna AB
LKSGF0.01N/A
N/A
Luks Group Vietnam Holdings Co., Ltd.
SPODF0.01N/A
N/A
SPOD LITHIUM CORP.

DBVT and

Correlation & Price change

A.I.dvisor tells us that DBVT and CRDF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBVT and CRDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
+5.76%
CRDF - DBVT
32%
Poorly correlated
+11.39%
TAOX - DBVT
29%
Poorly correlated
-5.37%
GLSI - DBVT
29%
Poorly correlated
+1.37%
PASG - DBVT
26%
Poorly correlated
-10.59%
ALT - DBVT
26%
Poorly correlated
-2.17%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+1.37%
ABOS - GLSI
49%
Loosely correlated
-3.57%
IMNM - GLSI
48%
Loosely correlated
+0.67%
CLDX - GLSI
47%
Loosely correlated
+0.96%
GBIO - GLSI
46%
Loosely correlated
-5.18%
BEAM - GLSI
45%
Loosely correlated
-4.46%
More